World Equity Group, Inc. Vertex Pharmaceuticals Inc Transaction History

World Equity Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 26, 2024	SELL	$314.42 - $351.91 $4.13 Million - $4.62 Million	-13,136 Closed	0 $0
Q1 2023 Aug 26, 2024	BUY	$283.23 - $323.1 $3.72 Million - $4.24 Million	13,136 New	13,136 $531 Million
Q2 2022 Sep 06, 2024	SELL	$234.96 - $292.55 $703,705 - $876,187	-2,995 Closed	0 $0
Q1 2022 Sep 06, 2024	BUY	$221.42 - $260.97 $663,152 - $781,605	2,995 New	2,995 $782 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.